 | • レポートコード：GIR-107A12322 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、心不全治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。心不全治療の種類別市場規模（薬物治療、外科的治療）、用途別市場規模（急性心不全、慢性心不全）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・心不全治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Novartis、Merck、Sanofi、Johnson & Johnson、AstraZeneca、GlaxoSmithKline、Amgen、Bayer、BMS、Cardiorentis、Cytokinetics、Ono Pharmaceuticals、Mylan、NCPC、Xinhua Group、Xudong Haipu Pharmaceutical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：薬物治療、外科的治療 ・用途別分析2016年-2026年：急性心不全、慢性心不全 ・心不全治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・心不全治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・心不全治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・心不全治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・心不全治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Heart Failure Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Heart Failure Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Heart Failure Treatment market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Heart Failure Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Drug Treatment
Surgical Treatment
Market segment by Application, can be divided into
Acute Heart Failure
Chronic Heart Failure
Market segment by players, this report covers
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
AstraZeneca
GlaxoSmithKline
Amgen
Bayer
BMS
Cardiorentis
Cytokinetics
Ono Pharmaceuticals
Mylan
NCPC
Xinhua Group
Xudong Haipu Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Heart Failure Treatment
1.2 Classification of Heart Failure Treatment by Type
1.2.1 Overview: Global Heart Failure Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Heart Failure Treatment Revenue Market Share by Type in 2020
1.2.3 Drug Treatment
1.2.4 Surgical Treatment
1.3 Global Heart Failure Treatment Market by Application
1.3.1 Overview: Global Heart Failure Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Acute Heart Failure
1.3.3 Chronic Heart Failure
1.4 Global Heart Failure Treatment Market Size & Forecast
1.5 Global Heart Failure Treatment Market Size and Forecast by Region
1.5.1 Global Heart Failure Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Heart Failure Treatment Market Size by Region, (2016-2021)
1.5.3 North America Heart Failure Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Heart Failure Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Heart Failure Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Heart Failure Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Heart Failure Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Heart Failure Treatment Market Drivers
1.6.2 Heart Failure Treatment Market Restraints
1.6.3 Heart Failure Treatment Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Heart Failure Treatment Product and Solutions
2.1.4 Pfizer Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Heart Failure Treatment Product and Solutions
2.2.4 Novartis Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Heart Failure Treatment Product and Solutions
2.3.4 Merck Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Merck Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Heart Failure Treatment Product and Solutions
2.4.4 Sanofi Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Heart Failure Treatment Product and Solutions
2.5.4 Johnson & Johnson Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Heart Failure Treatment Product and Solutions
2.6.4 AstraZeneca Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 AstraZeneca Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Heart Failure Treatment Product and Solutions
2.7.4 GlaxoSmithKline Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Amgen
2.8.1 Amgen Details
2.8.2 Amgen Major Business
2.8.3 Amgen Heart Failure Treatment Product and Solutions
2.8.4 Amgen Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Amgen Recent Developments and Future Plans
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business
2.9.3 Bayer Heart Failure Treatment Product and Solutions
2.9.4 Bayer Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bayer Recent Developments and Future Plans
2.10 BMS
2.10.1 BMS Details
2.10.2 BMS Major Business
2.10.3 BMS Heart Failure Treatment Product and Solutions
2.10.4 BMS Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 BMS Recent Developments and Future Plans
2.11 Cardiorentis
2.11.1 Cardiorentis Details
2.11.2 Cardiorentis Major Business
2.11.3 Cardiorentis Heart Failure Treatment Product and Solutions
2.11.4 Cardiorentis Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Cardiorentis Recent Developments and Future Plans
2.12 Cytokinetics
2.12.1 Cytokinetics Details
2.12.2 Cytokinetics Major Business
2.12.3 Cytokinetics Heart Failure Treatment Product and Solutions
2.12.4 Cytokinetics Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Cytokinetics Recent Developments and Future Plans
2.13 Ono Pharmaceuticals
2.13.1 Ono Pharmaceuticals Details
2.13.2 Ono Pharmaceuticals Major Business
2.13.3 Ono Pharmaceuticals Heart Failure Treatment Product and Solutions
2.13.4 Ono Pharmaceuticals Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Ono Pharmaceuticals Recent Developments and Future Plans
2.14 Mylan
2.14.1 Mylan Details
2.14.2 Mylan Major Business
2.14.3 Mylan Heart Failure Treatment Product and Solutions
2.14.4 Mylan Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Mylan Recent Developments and Future Plans
2.15 NCPC
2.15.1 NCPC Details
2.15.2 NCPC Major Business
2.15.3 NCPC Heart Failure Treatment Product and Solutions
2.15.4 NCPC Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 NCPC Recent Developments and Future Plans
2.16 Xinhua Group
2.16.1 Xinhua Group Details
2.16.2 Xinhua Group Major Business
2.16.3 Xinhua Group Heart Failure Treatment Product and Solutions
2.16.4 Xinhua Group Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Xinhua Group Recent Developments and Future Plans
2.17 Xudong Haipu Pharmaceutical
2.17.1 Xudong Haipu Pharmaceutical Details
2.17.2 Xudong Haipu Pharmaceutical Major Business
2.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Product and Solutions
2.17.4 Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Xudong Haipu Pharmaceutical Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Heart Failure Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Heart Failure Treatment Players Market Share
3.2.2 Top 10 Heart Failure Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Heart Failure Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Heart Failure Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Heart Failure Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Heart Failure Treatment Revenue Market Share by Application (2016-2021)
5.2 Heart Failure Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Heart Failure Treatment Revenue by Type (2016-2026)
6.2 North America Heart Failure Treatment Revenue by Application (2016-2026)
6.3 North America Heart Failure Treatment Market Size by Country
6.3.1 North America Heart Failure Treatment Revenue by Country (2016-2026)
6.3.2 United States Heart Failure Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Heart Failure Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Heart Failure Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Heart Failure Treatment Revenue by Type (2016-2026)
7.2 Europe Heart Failure Treatment Revenue by Application (2016-2026)
7.3 Europe Heart Failure Treatment Market Size by Country
7.3.1 Europe Heart Failure Treatment Revenue by Country (2016-2026)
7.3.2 Germany Heart Failure Treatment Market Size and Forecast (2016-2026)
7.3.3 France Heart Failure Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Heart Failure Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Heart Failure Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Heart Failure Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Heart Failure Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Heart Failure Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Heart Failure Treatment Market Size by Region
8.3.1 Asia-Pacific Heart Failure Treatment Revenue by Region (2016-2026)
8.3.2 China Heart Failure Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Heart Failure Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Heart Failure Treatment Market Size and Forecast (2016-2026)
8.3.5 India Heart Failure Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Heart Failure Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Heart Failure Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Heart Failure Treatment Revenue by Type (2016-2026)
9.2 South America Heart Failure Treatment Revenue by Application (2016-2026)
9.3 South America Heart Failure Treatment Market Size by Country
9.3.1 South America Heart Failure Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Heart Failure Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Heart Failure Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Heart Failure Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Heart Failure Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Heart Failure Treatment Market Size by Country
10.3.1 Middle East & Africa Heart Failure Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Heart Failure Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Heart Failure Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Heart Failure Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Heart Failure Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Heart Failure Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Heart Failure Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Heart Failure Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Heart Failure Treatment Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Heart Failure Treatment Product and Solutions
Table 9. Pfizer Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Heart Failure Treatment Product and Solutions
Table 13. Novartis Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Merck Corporate Information, Head Office, and Major Competitors
Table 15. Merck Major Business
Table 16. Merck Heart Failure Treatment Product and Solutions
Table 17. Merck Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Heart Failure Treatment Product and Solutions
Table 21. Sanofi Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 23. Johnson & Johnson Major Business
Table 24. Johnson & Johnson Heart Failure Treatment Product and Solutions
Table 25. Johnson & Johnson Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 27. AstraZeneca Major Business
Table 28. AstraZeneca Heart Failure Treatment Product and Solutions
Table 29. AstraZeneca Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Heart Failure Treatment Product and Solutions
Table 33. GlaxoSmithKline Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Amgen Corporate Information, Head Office, and Major Competitors
Table 35. Amgen Major Business
Table 36. Amgen Heart Failure Treatment Product and Solutions
Table 37. Amgen Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bayer Corporate Information, Head Office, and Major Competitors
Table 39. Bayer Major Business
Table 40. Bayer Heart Failure Treatment Product and Solutions
Table 41. Bayer Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. BMS Corporate Information, Head Office, and Major Competitors
Table 43. BMS Major Business
Table 44. BMS Heart Failure Treatment Product and Solutions
Table 45. BMS Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Cardiorentis Corporate Information, Head Office, and Major Competitors
Table 47. Cardiorentis Major Business
Table 48. Cardiorentis Heart Failure Treatment Product and Solutions
Table 49. Cardiorentis Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Cytokinetics Corporate Information, Head Office, and Major Competitors
Table 51. Cytokinetics Major Business
Table 52. Cytokinetics Heart Failure Treatment Product and Solutions
Table 53. Cytokinetics Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Ono Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 55. Ono Pharmaceuticals Major Business
Table 56. Ono Pharmaceuticals Heart Failure Treatment Product and Solutions
Table 57. Ono Pharmaceuticals Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Mylan Corporate Information, Head Office, and Major Competitors
Table 59. Mylan Major Business
Table 60. Mylan Heart Failure Treatment Product and Solutions
Table 61. Mylan Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. NCPC Corporate Information, Head Office, and Major Competitors
Table 63. NCPC Major Business
Table 64. NCPC Heart Failure Treatment Product and Solutions
Table 65. NCPC Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Xinhua Group Corporate Information, Head Office, and Major Competitors
Table 67. Xinhua Group Major Business
Table 68. Xinhua Group Heart Failure Treatment Product and Solutions
Table 69. Xinhua Group Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Xudong Haipu Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 71. Xudong Haipu Pharmaceutical Major Business
Table 72. Xudong Haipu Pharmaceutical Heart Failure Treatment Product and Solutions
Table 73. Xudong Haipu Pharmaceutical Heart Failure Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Heart Failure Treatment Revenue (USD Million) by Players (2019-2021)
Table 75. Global Heart Failure Treatment Revenue Share by Players (2019-2021)
Table 76. Breakdown of Heart Failure Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Heart Failure Treatment Players Head Office, Products and Services Provided
Table 78. Heart Failure Treatment Mergers & Acquisitions in the Past Five Years
Table 79. Heart Failure Treatment New Entrants and Expansion Plans
Table 80. Global Heart Failure Treatment Revenue (USD Million) by Type (2016-2021)
Table 81. Global Heart Failure Treatment Revenue Share by Type (2016-2021)
Table 82. Global Heart Failure Treatment Revenue Forecast by Type (2021-2026)
Table 83. Global Heart Failure Treatment Revenue by Application (2016-2021)
Table 84. Global Heart Failure Treatment Revenue Forecast by Application (2021-2026)
Table 85. North America Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Heart Failure Treatment Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Heart Failure Treatment Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Heart Failure Treatment Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Heart Failure Treatment Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Heart Failure Treatment Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Heart Failure Treatment Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Heart Failure Treatment Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Heart Failure Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Heart Failure Treatment Picture
Figure 2. Global Heart Failure Treatment Revenue Market Share by Type in 2020
Figure 3. Drug Treatment
Figure 4. Surgical Treatment
Figure 5. Heart Failure Treatment Revenue Market Share by Application in 2020
Figure 6. Acute Heart Failure Picture
Figure 7. Chronic Heart Failure Picture
Figure 8. Global Heart Failure Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Heart Failure Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Heart Failure Treatment Revenue Market Share by Region (2016-2026)
Figure 11. Global Heart Failure Treatment Revenue Market Share by Region in 2020
Figure 12. North America Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Heart Failure Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Heart Failure Treatment Market Drivers
Figure 18. Heart Failure Treatment Market Restraints
Figure 19. Heart Failure Treatment Market Trends
Figure 20. Pfizer Recent Developments and Future Plans
Figure 21. Novartis Recent Developments and Future Plans
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Sanofi Recent Developments and Future Plans
Figure 24. Johnson & Johnson Recent Developments and Future Plans
Figure 25. AstraZeneca Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Recent Developments and Future Plans
Figure 27. Amgen Recent Developments and Future Plans
Figure 28. Bayer Recent Developments and Future Plans
Figure 29. BMS Recent Developments and Future Plans
Figure 30. Cardiorentis Recent Developments and Future Plans
Figure 31. Cytokinetics Recent Developments and Future Plans
Figure 32. Ono Pharmaceuticals Recent Developments and Future Plans
Figure 33. Mylan Recent Developments and Future Plans
Figure 34. NCPC Recent Developments and Future Plans
Figure 35. Xinhua Group Recent Developments and Future Plans
Figure 36. Xudong Haipu Pharmaceutical Recent Developments and Future Plans
Figure 37. Global Heart Failure Treatment Revenue Share by Players in 2020
Figure 38. Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Heart Failure Treatment Revenue Market Share in 2020
Figure 40. Global Top 10 Players Heart Failure Treatment Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Heart Failure Treatment Revenue Share by Type in 2020
Figure 43. Global Heart Failure Treatment Market Share Forecast by Type (2021-2026)
Figure 44. Global Heart Failure Treatment Revenue Share by Application in 2020
Figure 45. Global Heart Failure Treatment Market Share Forecast by Application (2021-2026)
Figure 46. North America Heart Failure Treatment Sales Market Share by Type (2016-2026)
Figure 47. North America Heart Failure Treatment Sales Market Share by Application (2016-2026)
Figure 48. North America Heart Failure Treatment Revenue Market Share by Country (2016-2026)
Figure 49. United States Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Heart Failure Treatment Sales Market Share by Type (2016-2026)
Figure 53. Europe Heart Failure Treatment Sales Market Share by Application (2016-2026)
Figure 54. Europe Heart Failure Treatment Revenue Market Share by Country (2016-2026)
Figure 55. Germany Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Heart Failure Treatment Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Heart Failure Treatment Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Heart Failure Treatment Revenue Market Share by Region (2016-2026)
Figure 63. China Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Heart Failure Treatment Sales Market Share by Type (2016-2026)
Figure 70. South America Heart Failure Treatment Sales Market Share by Application (2016-2026)
Figure 71. South America Heart Failure Treatment Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Heart Failure Treatment Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Heart Failure Treatment Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Heart Failure Treatment Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Heart Failure Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界の心臓ブロック治療市場 2021：企業別、地域別、種類・用途別 The Heart Blocks Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界の心肺バイパス装置市場 2021：企業別、地域別、種類・用途別 The Heart-Lung Bypass Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の心血管疾患治療用タンパク質市場 2021：企業別、地域別、種類・用途別 The Therapeutic Proteins for Cardiovascular Disorders Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…
- 世界の故障解析検査装置市場 2021：企業別、地域別、種類・用途別 The Failure Analysis Test Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の軟骨無形成症治療市場 2021：企業別、地域別、種類・用途別 The Achondroplasia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…